DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Xaliproden
Xaliproden
Alzheimer's Disease Clinical Trials
(12) United States Patent (10) Patent No.: US 9,005,660 B2 Tygesen Et Al
Methods and Combination Therapies for Treating Alzheimer's Disease
Trend Is Reported on a Per Member Per Year (PMPY) Basis
Granule Cells in the CA3 Area
The Management of Motor Neurone Disease
Pharmaceutical Composition and Dosage Forms for Administration of Hydrophobic Drugs
COMP Agenda of the 3-4 November 2016 Meeting
FF #197 CIPN. 3Rd Ed
Mitigating the Inhibition of Human Bile Salt Export Pump by Drugs
Involvement of Serotonergic System in Oxaliplatin-Induced Neuropathic Pain
(12) Patent Application Publication (10) Pub. No.: US 2010/0184806 A1 Barlow Et Al
Towards Improving Outcomes for Patients with ALS
Neuronal 5-HT Receptors and SERT
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
(12) Patent Application Publication (10) Pub. No.: US 2004/0120895 A1 Dugger, III (43) Pub
Chemotherapy-Induced Neuropathy: Prevention and Treatment
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Top View
Atc Index 2010
A Brief Review of Alzheimer's Disease
Assessing the Anti-Inflammatory Activity of the Anxiolytic Drug
Antioxidant Supplementation in the Treatment of Neurotoxicity Induced by Platinum-Based Chemotherapeutics—A Review
Diagnosis, Treatment and Research for ALS: Old and New Ideas
ICH Protocol Template
Known Bioactive Library: Tocriscreen Mini Library 2
Customs Tariff - Schedule Xxi - 1
Therapeutic Agents for Oxaliplatin-Induced Peripheral Neuropathy; Experimental and Clinical Evidence
Alzheimer's Disease
Drug Repurposing to Treat Glucocorticoid Resistance in Asthma Alberta L
Harmonized Tariff Schedule of the United States (2006) (Rev
Mechanisms of Cell Death and Treatment Prospects in Motor Neuron Disease
NCCN Task Force Report: Management of Neuropathy in Cancer
AD Causes Queries Appendix 9A-1
Ep 2316468 A1
Harmonized Tariff Schedule of the United States (2006) (Rev
Harmonized Tariff Schedule of the United States (2003) -- Supplement 1 Annotated for Statistical Reporting Purposes
Draft COMP Agenda 17-19 April 2018
Combination Drug Therapy for the Management of Alzheimer's Disease
Chemotherapy-Induced Peripheral Neuropathy: Prevention and Treatment Strategies
Serotonin 5-HT2B Receptor Antagonism Is Fundamental For
(12) United States Patent (10) Patent No.: US 7,838,552 B2 Davis Et Al
Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving